Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedIFRSThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
In the medical institutions segment, revenue increased due to an increase in the number of key locations supported, optimization of monthly fees, an increase in patient numbers at U.S. clinics, and the addition of new consolidated subsidiaries, while costs for evaluating new businesses and upfront investment for opening OBL facilities increased. In the hospice segment, the commencement of operations at 15 new facilities contributed to revenue, but lower unit prices following the revision of medical service fees, as well as initial costs and depreciation associated with new openings, put pressure on profit. In the home-visit nursing segment, revenue increased as operations expanded at new locations, but personnel and recruitment expenses increased due to initial costs and advance hiring.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥14,159 million (YoY +9.0%) |
| Operating profit | ¥32 million (YoY -95.7%) |
| Ordinary income | ¥-192 million |
| Profit attributable to owners of the parent | ¥-281 million |
| Net income per share | −¥9.60 |
| Equity ratio | End of the current fiscal period 33 / End of previous period 34.1 |
| Total assets | ¥101,144 million |
| Net assets | ¥33,825 million |
| Cash and cash equivalents at end of period | ¥18,327 million |
| Full-year earnings forecast | Net Sales ¥64,600 million (YoY +18.9%) / Operating profit ¥3,800 million (YoY -34.3%) / Ordinary income ¥2,800 million (YoY -45.2%) / Net income ¥1,100 million (YoY -59.9%) |
| Annual Dividend Forecast | ¥0 → ¥0（0.0%） |
| Segment revenue | Medical institutions ¥4,510 million (YoY +9.1%), Hospice ¥4,447 million (YoY +16.0%), Home-Visit Nursing ¥3,302 million (YoY +2.3%), Medical Care Residences ¥1,923 million (YoY +5.5%) |
| Segment profit | Medical institutions ¥381 million (YoY -50.2%), Hospice ¥-102 million, Home-Visit Nursing ¥91 million (YoY -73.4%), Medical Care Residences ¥-93 million |
| Depreciation and amortization | ¥1,371 million |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement Not disclosed |
| Changes in the scope of consolidation | New 0 companies / Excluded 0 companies / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 29,990,400 shares |
| Treasury Shares at Period-End | 675,124 shares |
| Factors Behind Changes in Business Performance | In the medical institutions segment, revenue increased due to an increase in the number of key locations supported, optimization of monthly fees, an increase in patient numbers at U.S. clinics, and the addition of new consolidated subsidiaries, while costs for evaluating new businesses and upfront investment for opening OBL facilities increased. In the hospice segment, the commencement of operations at 15 new facilities contributed to revenue, but lower unit prices following the revision of medical service fees, as well as initial costs and depreciation associated with new openings, put pressure on profit. In the home-visit nursing segment, revenue increased as operations expanded at new locations, but personnel and recruitment expenses increased due to initial costs and advance hiring. |
Items this document does not state (12)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased due to an increase in the number of key locations supported in Japan, optimization of monthly fees, an increase in patient numbers at U.S. clinics, the addition of new consolidated subsidiaries, and the opening and commencement of operations at new hospice facilities and home-visit nursing stations. Profit declined due to costs related to evaluating new businesses, upfront investment for the opening of OBL facilities in the United States, lower unit prices following the revision of medical service fees, initial costs and depreciation associated with new openings, increases in personnel and recruitment expenses, and higher finance costs resulting from increased borrowings.